Patent US5075112A successfully refreshed from Google Patents.
US5075112A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
Assignee: Cosciens Biopharma Inc
•
Filing: 1990-02-12
•
Granted: 1991-12-24
•
Expires: 2010-02-12
Abstract
Abstract Method of, and dosage unit for, inhibiting angiogenesis in an aminal having an intestinal wall by administering to the animal, orally or anally, an effective amount of shark cartilage, particularly finely divided shark cartilage in solid dosage form such as a tablet, capsule, suppository, for passing through the intestinal wall of the animal as a suspension.
Inventors
- 👤 Irwin W. Lane
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 06:05
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/56; A61K35/60; Y; Y10; Y10S; Y10S424/00; Y10S424/15
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
91 words
A method of inhibiting angiogenesis in an animal having an intestinal wall comprising administering to said animal an effective amount of shark cartilage for passing through said intestinal wall as a suspension, said effective amount being about 0.2 gram to about 2 grams per day per each 15 lbs. of body weight of said animal, said shark cartilage being administered in solid dosage form selected from the group consisting of a capsule, a table and a suppository and said solid dosage form prepared from shark cartilage screened to substantially 300 mesh.
Claim 2
Independent Claim
91 words
A method of inhibiting angiogenesis in an animal having an intestinal wall comprising administering to said animal an effective amount of shark cartilage for passing through said intestinal wall as a suspension, said effective amount being about 0.2 gram to about 2 grams per day per each 15 lbs. of body weight of said animal, said shark cartilage being administered in solid dosage form selected from the group consisting of a capsule, a table and a suppository and said solid dosage form prepared from shark cartilage screened to substantially 300 mesh.
Claim 3
Dependent Claim
29 words
Method according to claim 1 wherein said effective amount is about 0.2 gram to about 2 grams per day per each 15 lbs. of body weight of said animal.
Claim 4
Dependent Claim
29 words
Method according to claim 2 wherein said effective amount is about 1 gram to about 2 grams per day per each 15 lbs. of body weight of said animal.
Claim 5
Dependent Claim
25 words
Method according to claim 2 wherein said effective amount is about 1 gram per day for each 15 lbs. of body weight of said animal.
Claim 6
Dependent Claim
42 words
Method according to claim 2 wherein said method is particularly useful for maintaining said inhibiting of angiogenesis and wherein said effective amount is about 0.2 gram to about 0.5 gram per day per each 15 lbs. of body weight of said animal.
Claim 7
Dependent Claim
14 words
Method according to claim 1 wherein said shark cartilage is finely divided shark cartilage.
Claim 8
Dependent Claim
16 words
Method according to claim 6 which comprises administering said shark cartilage in a solid dosage form.
Claim 9
Dependent Claim
12 words
Method according to claim 7 wherein said solid dosage is a capsule.
Claim 10
Dependent Claim
13 words
Method according to claim 7 wherein said solid dosage form is a tablet.
Claim 11
Dependent Claim
13 words
Method according to claim 7 wherein said solid dosage form is a suppository.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-12-23 | 1995-06-24 | 1995-12-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-12-23 | 1999-06-24 | 1999-12-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-12-23 | 2003-06-24 | 2003-12-24 | $7700.00 | Window Closed / Lapsed |